COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Mississippi patients with a documented clinical need may be eligible for compounded tirzepatide.
Mississippi has among the highest diabetes and obesity rates in the nation, making access to GLP-1 medications especially relevant. Compounding Finder helps Mississippi residents connect with licensed pharmacies that deliver statewide.
Yes. The Mississippi Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.
.png){kind=spacer}
